Article

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer

2023-08-09

Abstract excerpt

<title>Abstract</title> <p>Background Accumulating evidence supports the significant role of human microbiome in development and therapeutic response of tumors. Circulating microbial DNA is non-invasive and could show a general view of the microbiome of host, making it a promising biomarker for cancers. However, whether circulating microbiome is associated with prognosis of non-small cell lung cancer (NSCLC) and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dde56ed7-5061-5ea8-8a71-865844d6a0b4
DOI: 10.21203/rs.3.rs-3175466/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerDOI 10.21203/rs.3.rs-3175466/v1Read

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerSemantic proximity Read

Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancerSemantic proximity Read

Microbial biomarker development for detection and prognosis of early-stage non-small cell lung cancerSemantic proximity Read

Gut Metatranscriptomics Based De Novo Assembly Reveals Microbial Signatures Predicting Immunotherapy outcomes in Non-Small Cell Lung CancerSemantic proximity Read

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer PatientsSemantic proximity Read

Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma.Semantic proximity Read

The characteristics of intratumoral microbial community reflect the development of lung adenocarcinomaSemantic proximity Read

Comprehensive analysis of microbiota signature across 32 cancer typesSemantic proximity Read

Gut Microbiome Diversity and Specific Composition During Immunotherapy in Japanese Responders with Non-Small Cell Lung CancerSemantic proximity Read

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces TogetherSemantic proximity Read

Unveiling the distinctive variations in multi-omics triggered by TP53 mutation in lung cancer subtypes: An insight from interaction among intratumoral microbiota, tumor microenvironment, and pathology.Semantic proximity Read

Multi-omics analysis reveals the impact of intratumor microbes on lung adenocarcinoma prognosis and ICB treatmentSemantic proximity Read